FDA Approves Easy-To-Use Naloxone: Antidote to Zohydro?
This article was originally published in RPM Report
Executive Summary
FDA’s recent approval of an auto-injection form of naloxone may be an opportunity to change the public perception of the agency’s priorities in the opioid and prescription drug abuse debate.